FLT3 p.Gln640SerfsTer8 signaling (Homo sapiens)
From WikiPathways
Description
Germline variant FLT3 p.Gln640SerfsTer8 lacks the catalytic kinase domain. However, the frameshift variant encodes a truncated protein variant that contains a short cytoplasmic segment which harbours two SH2-binding STAT3 docking sites. This results in enhanced STAT3 tyrosine phosphorylation followed by increase STAT3-dependent transcription activity. Expression of FLT3 p.Gln640SerfsTer8 in T lymphoblast model cell line BW5147 results in increased proliferation and increased cell surface expression of inflammatory chemokine receptors CCR5 and CCR6, which are involved in migration of immune cells to mucosal tissues and inflamed areas.
Quality Tags
Ontology Terms
Saving...Bibliography
- Ulaganathan VK; ''TraPS-VarI: Identifying genetic variants altering phosphotyrosine based signalling motifs.''; Sci Rep, 2020 PubMed Europe PMC Scholia
- Yu H, Kortylewski M, Pardoll D; ''Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.''; Nat Rev Immunol, 2007 PubMed Europe PMC Scholia
- ''Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells ''; Eur J Immunol, 2007 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| CCR5 | Protein | P51681 (Uniprot-SwissProt)  | |
| CCR6 | Protein | P51684 (Uniprot-SwissProt) | |
| Cell Cycle Progression | Pathway | WP179 (WikiPathways) | |
| Chemotaxis to Mucosal &/or Inflammed Tissues | Pathway | ||
| FLT3 | Protein | P36888 (Uniprot-SwissProt) | |
| STAT3 | Protein | P40763 (Uniprot-SwissProt) |
Annotated Interactions
No annotated interactions
